| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
John D. Dingell VA Medical Center [Y. Z., A. K. R., R. T., L. F., M. B., J. A. F.] and Karmanos Cancer Institute, Detroit, Michigan 48201 [Y. Z., A. K. R., R. T., L. F., M. B., E. C. V. B., J. A. F.]; Molecular Medicine Research Institute, Mountain View, California 94043 [M. I. D]; and Center International de Rescherches Dermatologigues Galderma, F. 06902 Valbonne, France [U. R., B. S.]
The addition of all-trans-retinoic acid has been found to mediate a G1 cell cycle phase arrest but not apoptosis in normal mammary epithelial cells. We have now found that addition of the novel retinoid 6-[3-(1-adamanty1)]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437), which appears to function through a pathway independent of retinoic acid nuclear receptors, results in an S-phase arrest that is preceded by a 4-fold elevation in the levels of the cyclin-cyclin dependent kinase (cdk) inhibitor p21WAF1/CIP1. Failure to inhibit E2F-1 activation of genes through its phosphorylation by the cyclin cdk2 kinase has been shown to result in S-phase arrest and apoptosis in a number of cell types. Although exposure of the normal mammary cells to CD437 does not result in modulation of cyclin A or cdk2 levels, an increase in E2F-1 levels and a marked inhibition of cyclin A/cdk2 kinase activity are observed. Exposure to CD437 results in enhanced E2F-1 binding to its DNA consensus sequences and transcriptional activity during S phase. We hypothesize that this enhanced E2F-1 transcriptional activity results in S-phase arrest and subsequent apoptosis that has been observed in other systems.
This article has been cited by other articles:
![]() |
C. Valli, G. Paroni, A. M. Di Francesco, R. Riccardi, M. Tavecchio, E. Erba, A. Boldetti, M. Gianni', M. Fratelli, C. Pisano, et al. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity Mol. Cancer Ther., September 1, 2008; 7(9): 2941 - 2954. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Farhana, M. I. Dawson, and J. A. Fontana Apoptosis Induction by a Novel Retinoid-Related Molecule Requires Nuclear Factor-{kappa}B Activation Cancer Res., June 1, 2005; 65(11): 4909 - 4917. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, X. Sun, J. T. LaMont, A. B. Pardee, and C. J. Li Selective killing of cancer cells by beta -lapachone: Direct checkpoint activation as a strategy against cancer PNAS, March 4, 2003; 100(5): 2674 - 2678. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Farhana, M. Dawson, A. K. Rishi, Y. Zhang, E. Van Buren, C. Trivedi, U. Reichert, G. Fang, M. W. Kirschner, and J. A. Fontana Cyclin B and E2F-1 Expression in Prostate Carcinoma Cells Treated with the Novel Retinoid CD437 Are Regulated by the Ubiquitin-mediated Pathway Cancer Res., July 1, 2002; 62(13): 3842 - 3849. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-B. Lin, P. O. P. Ts'o, S.-K. Sun, K.-B. Choo, F.-Y. Yang, Y.-P. Lim, H.-L. Tsai, and L.-C. Au Inhibition of Thymidylate Synthase Activity by Antisense Oligodeoxynucleotide and Possible Role in Thymineless Treatment Mol. Pharmacol., September 1, 2001; 60(3): 474 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Potapova, M. Gorospe, F. Bost, N. M. Dean, W. A. Gaarde, D. Mercola, and N. J. Holbrook c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma Cells J. Biol. Chem., August 4, 2000; 275(32): 24767 - 24775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |